DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/cr7wvx/global_hiv) has announced the addition of the "Global HIV Epidemiology and Patient Flow Analysis - 2012" report to their offering.
Fore Pharma announced the results of its HIV patient population study in a new report Global HIV Epidemiology and Patient Flow Analysis - 2012'. The report provides insights into HIV epidemiology, HIV diagnosed patients, and HIV treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of HIV derived from epidemiological analysis, percentage of patients diagnosed with HIV, and percentage of patients treated with HIV therapy.
The study helps executives estimate HIV market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of HIV prevalence, HIV diagnosis rate, and HIV treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.
Key Features of the Report:
- HIV: Disease Definition
- HIV Patient Flow
- HIV Prevalence
- HIV Diagnosed Patients
- HIV Treated Patients
For more information visit http://www.researchandmarkets.com/research/cr7wvx/global_hiv
Source: Research and Markets